GASTRIC ADENOCARCINOMA
Clinical trials for GASTRIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stomach cancer surgery combo trial halted early
Disease control TerminatedThis study looked at whether removing the main stomach tumor and the single spot it spread to, plus chemotherapy, helps people live longer than chemotherapy alone. It was for people with stage IV stomach cancer that had only spread to one other place. The trial was stopped early …
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated May 17, 2026 07:06 UTC
-
Stomach cancer chemo study halted early after enrolling only 3 patients
Disease control TerminatedThis study compared two ways of giving FLOT chemotherapy to people with stomach or gastroesophageal junction cancer. One group received all four cycles before surgery, while the other had two cycles before and two after surgery. The study was stopped early after enrolling only 3 …
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
Cancer drug trial halted early: PRT7732 studied for rare gene mutation
Disease control TerminatedThis early-stage study tested an experimental oral drug called PRT7732 in people with advanced solid tumors (like lung or stomach cancer) that have a specific genetic change called SMARCA4. The main goals were to check safety, find the right dose, and see if the drug shrinks tumo…
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Cancer combo trial halted early: what we know
Disease control TerminatedThis study tested a combination of two drugs, niraparib and dostarlimab, in adults with advanced solid tumors that had DNA repair problems or were sensitive to platinum chemotherapy. The goal was to see how many patients' tumors shrank or disappeared. The trial was stopped early …
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Stomach cancer drug combo trial halted early – what we know
Disease control TerminatedThis study tested a new drug (DKN-01) combined with an immunotherapy (tislelizumab) and chemotherapy for people with advanced stomach or gastroesophageal junction cancer that could not be removed by surgery. The trial aimed to see if the combination was safe and could slow cancer…
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Leap Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New chemo combo for stomach cancer shows promise in early trial
Disease control TerminatedThis study tested a combination of chemotherapy drugs for people with stomach cancer that has spread to the lining of the belly. The drugs were given directly into the belly and through a vein, along with oral medication. The goal was to see if this approach could help patients l…
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:42 UTC